Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProfMOF is a Norwegian materials science and biotechnology company that specializes in the development and production of Metal-Organic Frameworks (MOFs). Founded as a spin-off from the University of Oslo, the company utilizes its expertise in highly porous crystalline materials to address challenges in drug delivery and medical imaging. Their platform focuses on the UiO-series of MOFs, which are known for their exceptional stability and biocompatibility, making them ideal for carrying therapeutic payloads. ProfMOF provides customized MOF solutions and R&D services to partners in the pharmaceutical and life sciences sectors. By tuning the pore size and chemical functionality of these frameworks, the company enables the controlled release of small molecules and biologics. Beyond healthcare, ProfMOF also applies its technology to gas storage and carbon capture applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProfMOF.